“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
Guy Brusselle(Ghent University Hospital), Ivo Abraham(American Association of Colleges of Pharmacy), Renaud Louis(University of Liège), Alain Michils(Erasmus Hospital), Charles Pilette(UCLouvain), Stefaan Vancayzeele(Novartis (Belgium)), Boudewijn Van de Maele(AZ Sint-Jan), Lieven Dupont(Universitair Ziekenhuis Leuven), Pascal Lecomte(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Karen MacDonald(Matrix Research (United States)), Christopher S. Lee(Boston College), MinKyoung Song(Matrix Research (United States)), Sandra Gurdain(Novartis (Belgium)), Christine Hermans(Novartis (Belgium)), Alain Delobbe(Centre hospitalier régional de la Citadelle)
Cited by 198
Related Papers
ESA CCI Soil Moisture for improved Earth system understanding: State-of-the art and future directions
|Remote Sensing of Environment|2017|1.5k
Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks
|Nature Genetics|2017|591
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
|Journal of Cardiac Failure|2022|406
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
|Journal of Cardiac Failure|2024|357